NCT01961505View on ClinicalTrials.gov

Topical Compound Tripterygium Wilfordii Hook F for Patients With Active Rheumatoid Arthritis

NACompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

September 30, 2015

Study Completion Date

December 31, 2016

Conditions
Active Rheumatoid Arthritis
Interventions
DRUG

Topical compound tripterygium

Topical compound tripterygium was applied for the pain and swollen joints on non-woven fabric for 1 hour, twice per day.

DRUG

Placebo

The topical placebo recipe composes viscous agent which matches by the sucrose, and the usage and dosage were the same as the topical compound tripterygium group.

All Listed Sponsors
lead

Guang'anmen Hospital of China Academy of Chinese Medical Sciences

OTHER

NCT01961505 - Topical Compound Tripterygium Wilfordii Hook F for Patients With Active Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter